reports
Navios Maritime Partners L.P. Announces the Date for the Release of Fi...
Navios Maritime Partners L.P. Announces the Date for the Release of First Quarter Ended March 31, 2024 Results, Conference Call and Webcast Conference Call & Webcast: Tuesday, May 14, 2024 at 8:30 am ET MONACO, May 10, 2024 (GLOBE NEWSWIRE) -- Navios Maritime Partners L.P. ("Navios Partners") (NYSE:NMM) announced today that it will host a conference call on Tuesday, May 14, 2024 at 8:30 am ET, at which time Navios Partners' senior management will provide highlights and commentary on earnings results for the first quarter ended March 31, 2024. The Company will report results for the firs...
FutureFuel Releases First Quarter 2024 Results
FutureFuel Releases First Quarter 2024 Results Reports Net Income of $4.3 Million or $0.10 per Diluted Share, and Adjusted EBITDA of $7.1 Million CLAYTON, Mo., May 10, 2024 (GLOBE NEWSWIRE) -- FutureFuel Corp. (NYSE: FF) (“FutureFuel”), a manufacturer of custom and performance chemicals and biofuels, today announced financial results for the first quarter ended March 31, 2024. First quarter 2024 Financial Highlights (all comparisons are with the first quarter of 2023) Revenues were $58.3 million, a decrease of 21% or $15.9 million compared to $74.2 million.Net income was $4.3 million,...
Entera Bio Reports Q1 2024 Financial Results and Provides Business Upd...
Entera Bio Reports Q1 2024 Financial Results and Provides Business Updates JERUSALEM, May 10, 2024 (GLOBE NEWSWIRE) -- Entera Bio Ltd. (NASDAQ: ENTX), (“Entera” or the “Company”) a leader in the development of orally delivered peptides and small therapeutic proteins, today reported financial results and key business updates for the quarter ended March 31, 2024. “Entera is off to a strong start in 2024 thanks to the growth strategy we implemented in 2023, expanding our N-Tab™ therapeutic pipeline with potential first in class oral GLP-2, GLP-1/glucagon and PTH(1-34) peptide treatmen...
Forward Reports Fiscal 2024 Second Quarter Results
Forward Reports Fiscal 2024 Second Quarter Results HAUPPAUGE, N.Y., May 10, 2024 (GLOBE NEWSWIRE) -- Forward Industries, Inc. (NASDAQ:FORD), a global design, sourcing and distribution group, today announced financial results for its second quarter ended March 31, 2024. Second Quarter Fiscal Year 2024 Financial Highlights Revenues were $7.8 million, a decrease of 19.6% from $9.7 million for 2023. Gross margin increased to 20.5% compared to 19.8% for 2023.Loss from continuing operations was $0.5 million compared to $0.1 million in 2023 and net loss was $0.6 million compared to $0.9 m...
Atrion Reports First Quarter 2024 Results
Atrion Reports First Quarter 2024 Results ALLEN, Texas, May 10, 2024 (GLOBE NEWSWIRE) -- Atrion Corporation (NASDAQ: ATRI) today announced its results for the first quarter ended March 31, 2024. Revenues for the first quarter of 2024 totaled $47.3 million compared to $40.0 million for the same period in 2023. For the just ended quarter, operating income was $3.1 million, down $1.3 million from the comparable 2023 period, primarily due to a one-time inventory write-off, and net income was $2.8 million, down $0.7 million from the same period in 2023. First quarter 2024 diluted earnings per...
Ocugen Announces Distribution of Series C Preferred Stock to Holders o...
Ocugen Announces Distribution of Series C Preferred Stock to Holders of its Common Stock MALVERN, Pa., May 10, 2024 (GLOBE NEWSWIRE) -- Ocugen, Inc. (Ocugen or the Company) (NASDAQ: OCGN), a biotechnology company focused on discovering, developing, and commercializing novel gene and cell therapies and vaccines, today announced that its Board of Directors declared a dividend of one one-thousandth of a share of newly designated Series C Preferred Stock, par value $0.01 per share, for each outstanding share of the Company’s common stock held of record as of 5:00 p.m. Eastern Time on May 20, ...
Longeveron Announces Board of Directors Planned Transitions
Longeveron Announces Board of Directors Planned Transitions Richard Kender, retired SVP of Business Development and Corporate Licensing for Merck & Co., Inc., has been appointed to the Longeveron BoardDr. Roger Hajjar, former head of R&D at Ring Therapeutics, has been nominated as a candidate for the Board, subject to election at the Company’s Annual Meeting of StockholdersNeha Motwani, former managing director and senior healthcare investment banker at William Blair, Truist, and Oppenheimer and Company, also has been nominated as a candidate for the Board, subject to election at the Compan...
89bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
89bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) SAN FRANCISCO, May 10, 2024 (GLOBE NEWSWIRE) -- 89bio, Inc. (the “Company” or “89bio”) (Nasdaq: ETNB), a clinical-stage biopharmaceutical company focused on the development and commercialization of innovative therapies for the treatment of liver and cardiometabolic diseases, today announced that the Compensation Committee of the Company’s Board of Directors approved the grant of non-qualified stock options to purchase an aggregate of 48,150 shares of the Company’s common stock to four new employees (the “Inducement Gra...
TELA Bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)...
TELA Bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) MALVERN, Pa., May 10, 2024 (GLOBE NEWSWIRE) -- TELA Bio, Inc. ("TELA Bio") (NASDAQ: TELA), a commercial-stage medical technology company focused on providing innovative soft-tissue reconstruction solutions, today announced that the Compensation Committee of the Board of Directors of TELA Bio approved inducement grants of restricted stock units covering 20,250 shares of its common stock to eleven newly-hired employees, with a grant date of May 6, 2024 (the "Grant Date"). The restricted stock units were granted pursua...
RLI Names Deb Millum as Vice President, Claim
PEORIA, Ill.--(BUSINESS WIRE)-- RLI Corp. (NYSE: RLI) -- RLI Corp. announced today the promotion of Deb Millum to Vice President, Claim. In her new role, Millum will assume executive leadership and oversight responsibility for RLI’s Transportation, Non-Transportation Auto and Personal Umbrella product claims. Millum joined RLI in 2017 as Director, Claim Counsel and was promoted to Assistant Vice President, Claim Counsel in 2019. She brings nearly 30 years of insurance claim and legal experience to her new role. Millum holds a Juris Doctorate degree from the University of Dayton School of Law...
Cassava Sciences Reports Q1 2024 Financial Results and Clinical Update...
Cassava Sciences Reports Q1 2024 Financial Results and Clinical Updates on Phase 3 Trials of Simufilam $126.3 Million In Total Gross Proceeds from Warrant Distribution.Over 1,900 Patients with Alzheimer’s Disease Are Randomized in Phase 3 Trials of Simufilam.Over 735 Patients Have Completed a Phase 3 Trial of Simufilam. AUSTIN, Texas, May 10, 2024 (GLOBE NEWSWIRE) -- Cassava Sciences, Inc. (Nasdaq: SAVA), a biotechnology company focused on Alzheimer’s disease, today reported financial results for first quarter ended March 31, 2024. Net income was $25.0 million compared to a net loss o...
CarGurus to Present at the J.P. Morgan 52nd Annual Global Technology, ...
CarGurus to Present at the J.P. Morgan 52nd Annual Global Technology, Media and Communications Conference CAMBRIDGE, Mass., May 10, 2024 (GLOBE NEWSWIRE) -- CarGurus, Inc. (Nasdaq: CARG), the No. 1 visited digital auto platform for shopping, buying, and selling new and used vehicles1, today announced that Jason Trevisan, Chief Executive Officer, is scheduled to participate in a fireside chat at the J.P. Morgan 52nd Annual Global Technology, Media and Communications Conference on Monday, May 20, 2024 at 1:50 PM ET. A webcast of the fireside chat will be accessible from the Investor Relati...
The Herzfeld Caribbean Basin Fund, Inc. Pays Quarterly Distribution
The Herzfeld Caribbean Basin Fund, Inc. Pays Quarterly Distribution MIAMI BEACH, Fla., May 10, 2024 (GLOBE NEWSWIRE) -- The Herzfeld Caribbean Basin Fund, Inc. (NASDAQ: CUBA) (the “Fund”) today announced that the Fund has made the following distribution pursuant to the Fund’s Managed Distribution Plan (the “Plan”): Declaration DateEx-DateRecord DatePayment DatePer Share02/12/202403/26/202403/27/202405/10/2024$0.135375 The distribution for stockholders has been paid in cash or shares of the Fund’s common stock at the election of stockholders. The total amount of cash distributed to all sto...
Senvest Capital Inc. Reports Results for the First Quarter Ended March...
Senvest Capital Inc. Reports Results for the First Quarter Ended March 31, 2024 MONTREAL, May 10, 2024 (GLOBE NEWSWIRE) -- Senvest Capital Inc. today reported net income attributable to common shareholders of $52.3 million or $21.17 per share for the three months ended March 31, 2024. This compares to net income attributable to common shareholders of $43.8 million or $17.66 per share for the same period in 2023 Financial statements are available online at Sedar+ CONSOLIDATED STATEMENTS OF INCOME (unaudited) (in millions of dollars, except per share amounts) For the three months ended ...
Senvest Capital Inc. annonce ses résultats pour le trimestre terminé l...
Senvest Capital Inc. annonce ses résultats pour le trimestre terminé le 31 mars 2024 MONTRĖAL, 10 mai 2024 (GLOBE NEWSWIRE) -- Senvest Capital Inc. a annoncé aujourd’hui un résultat net attribuable aux actionnaires ordinaires de 52,3 M$ ou 21,17 $ par action pour les trois mois terminés le 31 mars 2024. Pour la période correspondante de 2023, elle avait inscrit un résultat net attribuable aux actionnaires ordinaires de 43,8 M$ ou 17,66 $ par action. Les états financiers sont disponibles sur le site Sedar+ ÉTAT CONSOLIDÉ DES RÉSULTATS (non vérifié) (en millions de dollars, sauf les...
Wayne Savings Bancshares, Inc. Announces 2024 Special Meeting Voting R...
Wayne Savings Bancshares, Inc. Announces 2024 Special Meeting Voting Results WOOSTER, Ohio, May 10, 2024 (GLOBE NEWSWIRE) -- On May 7, 2024, Wayne Savings Bancshares, Inc. (OTCQX: WAYN) (the “Company”) shareholders approved the agreement for the merger of Wayne Savings Bancshares, Inc. and Main Street Financial Services Corp. The inspector of elections delivered its final report of voting results for each of the matters submitted to a vote. Proposal 1: To adopt and approve the Agreement and Plan of Merger. According to the final report of the inspector of election tabulation voting ...
Esperion Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)...
Esperion Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) ANN ARBOR, Mich., May 10, 2024 (GLOBE NEWSWIRE) -- Esperion (NASDAQ: ESPR) today announced that on May 8, 2024, the Company granted 16 new employees 62,300 restricted stock units (RSUs) under Esperion’s 2017 Inducement Equity Incentive Plan. The 2017 Inducement Equity Incentive Plan is used exclusively for the grant of equity awards to individuals who were not previously an employee or non-employee director of Esperion (or following a bona fide period of non-employment), as an inducement material to such individual...
Nova Vision Acquisition Corp. Announces Additional Contribution to Tru...
Nova Vision Acquisition Corp. Announces Additional Contribution to Trust Account to Extend Period to Consummate Business Combination to June 10, 2024 Singapore, May 10, 2024 (GLOBE NEWSWIRE) -- Nova Vision Acquisition Corp. (NASDAQ: NOVV, the “Company”), a special purpose acquisition company, announced today that Nova Pulsar Holdings Limited, the Company’s initial public offering sponsor (“Sponsor”), has deposited into the Company’s trust account (the “Trust Account”) an aggregate of $69,763.37 (representing approximately $0.045 per ordinary share issued at the Company’s initial public of...
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.